Efficacy of recombinant interferon-alpha (rIFN-α) in polycythaemia vera: A study of 17 patients and an analysis of published data

British Journal of Haematology

Volumn 92, Issue 1, 1996, Pages 55-59

  Taylor, P C ^a   Dolan, G ^b   Ng, J P ^c   Paul, B ^d   Collin, R ^e   Reilly, J T ^f  

^a Rotherham District General   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c Barnsley District General   (United Kingdom)

^d Bassetlaw General   (United Kingdom)

^e Chesterfield Royal Infirmary   (United Kingdom)

^f NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Polycythaemia vera; Pruritus; interferon

Indexed keywords

BUSULFAN; HYDROXYUREA; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MYALGIA; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PRURITUS; SIDE EFFECT; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT REDUCTION;

EID: 0030071570     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.00303.x     Document Type: Article

References (36)

1. Adamson, J.W., Fialkow, P.J., Murphy, S., Prchal, J.F. & Steinmann, L. (1976) Polycythemia vera: stem cell and probable clonal origin of the disease. New England Journal of Medicine, 295, 913-919.
2. Ariad, S. & Bezwoda, W.R. (1991) α-interferon for polycythemia vera. Blood, 77, 670.
3. Barosi, G., Libertato, L.N., Costa, A. & Ascari, E. (1989) Cytoreductive effects of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia. Blut, 58 271-274.
4. Berk, P.D., Golsberg, C.D., Donovan, P.B., Fruchtman, S.M., Berlin, N.I. & Wasserman, L.R. (1986) Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Seminars in Haematology, 23, 132-143.
5. Berlin, N.I. (1975) Diagnosis and classification of the polycythemias. Seminars in Hematology, 12, 339-351.
6. Cacciola, E., Giustolisi, R., Gugleilmo, P., Di Raimondo, F., Cacciola, E. & Calogero, R.D. (1991) Recombinant interferon α in the treatment of polycythemia vera. Blood, 77, 2790.
7. Costello, G., Lerza, R., Cerruti, A., Cavallini, D., Bugliolo, C. & Pannacciulli, I. (1994) The in vitro effect of recombinant interferon-α-2a on circulating haemopoietic progenitors in polycythaemia vera. British Journal of Haematology, 87, 621-623.
8. Dallman, P.R., Beutler, E. & Finch, C.H. (1978) Effects of iron deficiency exclusive of anaemia. British Journal of Haematology, 40, 179-184.
9. Denman, S.T. (1986) A review of pruritus. Journal of the American Academy of Dermatology, 14, 375-392.
10. de Wolf, J.Th.M., Hendricks, D.W., Egger, R.C., Esselink, M.T., Halie, M.R. & Vellenga, E. (1991) α-interferon for intractable pruritus in polycythaemia vera. Lancet, i, 241.
11. Finelli. C., Gugliotta, L., Gamberi, B., Vianelli, N., Visani, G. & Tura, S. (1993) Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa. American Journal of Hematology, 43, 316-318.
12. Fjellner, B. & Hägermark, O. (1979) Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement. Acta Dermatologica et Venereologica, 59, 505-512.
13. Gilbert, H.S., Warner, R.R.P. & Wasserman, L.R. (1966) A study of histamine in myeloproliferative disease. Blood, 28, 795-806.
14. Giles, F.J., Gray, A.G., Brozovic, M., Grant, I.D., Machin, S.J., Richards, J.D.M., Venutas, S., Singer, C.R., Yong, K.L., Davies, S.C., Hoffbrand, A.V., Mehta, A.B., Thomas, M.J.G. & Goldstone, A.H. (1988) Alpha-interferon therapy for essential thrombocythaemia. Lancet, ii, 70-72.
15. Giles, F.J., Gray, A.G., Carmichael, D.S., Williams, Y.F., Brosovic, M. & Goldstone, A.H. (1991) Resistant polycythaemia vera: successful therapy with non recombinant or recombinant alpha interferon. British Journal of Haematology, 77, (Suppl. 1), 663.
16. Hansmann, E., Bremer, K., Grüntjens-Prinsen, G. & Kemper, J. (1993) Recombinant interferon (IFN) α-2B therapy of chronic myeloproliferative disorders (CMPD). XIIth Meeting of the International Society of Haematology. Vienna, 28 August to 3 September 1993.
17. Hoffman, R. & Boswell, H.S. (1991) Polycythemia vera. In: Haematology: Basic Principles and Practice (ed. by R. Hoffman et al). Churchill Livingstone, New York.
18. Kaplan, M.E., Mack, K., Goldberg, J.D., Donovan, P.B., Berk, P.D. & Wasserman, L.R. (1986) Long-term management of polycythaemia vera with hydroxyurea. Seminars in Haematology, 23, 167-171.
19. Löfvenberg, E. & Wahlin, A. (1988) Management of polycythaemia vera, essential thrombocythaemia and myelofibrosis with hydroxyurea. European Journal of Haematology, 41, 375-381.
20. Ludwig, H., Linkesch, W., Gisslinger, H., Fritz, E., Sinzinger, H., Radaszkiewicz, T., Chott, A., Roswitha, F. & Micksche, M. (1987) Interferon alfa corrects thrombocytosis in patients with myeloproliferative disorders. Cancer Immunology and Immunotherapy, 25, 266-273.
21. Messora, C., Bensi, L. Vecchi, A., Longo, R., Giacobbi, F., Temperani, P., Bevini, M., Emilia, G. & Sacchi, S. (1994) Cytogenetic conversion in a case of polycythaemia vera treated with interferon-alpha. British Journal of Haematology, 86, 402-404.
22. Muller, E.W., de Wolf, J.Th.M., Egger, R., Wijermans, P.W., Huijgens, P.C., Halie, M.R. & Vellenga, H. (1998) Long-term treatment with interferon-α2b for severe pruritus in patients with polycythaemia vera. British Journal of Haematology, 89, 313-318.
23. Najean, Y., Dresch, C. & Rain, J-D. (1994) The very-long-term course of polycythaemia: a complement to the previously published data of the Polycythaemia Vera Study Group. British Journal of Haematology, 86, 233-235.
24. Nand, S., Messmore, H., Fischer, S.G., Bird, M.L., Schultz, W. & Fischer, R.I. (1990) Leukemic transformation in polycythemia vera: analysis of risk factors. American Journal of Hematology, 34, 32-36.
25. Papineschi, F., Bucalossi, A., Capochiani, E., Benedetti, E., Bramanti, E., Dastoli, G., Dispensa, E., Benedetti, E. & Spremolla, G. (1994) Recombinant α2a interferon and polycythaemia vera: clinical results and biological evaluation by means of Fourier-transform infrared microspectroscopy. European Journal of Haematology, 53, 213-217.
26. Rector, W.G., Fortuin, N.J. & Conley, C.L. (1982) Nonhematologic effects of chronic iron deficiency: a study of patients with polycythemia vera treated solely with venesections. Medicine (Baltimore), 61, 382-389.
27. Salem, H.H., Van der Weyden, M.B., Young, I.F. & Wiley, J.S. (1982) Pruritus and severe iron deficiency in polycythaemia. British Medical Journal 285, 91-92.
28. Seewan, H.L., Zikulnig, R., Gallhofer, G. & Schmid, C. (1991) Treatment of thrombocytosis in chronic myeloproliferative disorders with interferon alfa-2b. European Journal of Cancer, 27, (Suppl. 4), 58-63.
29. Silver, R.T. (1993) Interferon-α2b: a new treatment for polycythemia vera. Annals of Internal Medicine, 119, 1091-1092.
30. Steinman, H.K., Kobza-Black, A., Lotti, T.M., Brunetti, L., Panconesti, E. & Greaves, M.W. (1987) Polycythaemia vera and water induced pruritus: blood histamine levels and cutaneous fibrinolytic activity before and after water challenge. British Journal of Dermatology, 116, 329-333.
31. Swerlick, R.A. (1988) Photochemotherapy treatment of pruritis associated with polycythemia vera. Journal of the American Academy of Dermatology, 13, 675-677.
32. Talpaz, M., Kantarjian, H.M., McCredie, K., Trujillo, J.M., Keating, M.J. & Gutterman, J.U. (1986) Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia. New England Journal of Medicine, 314, 1065-1069.
33. Talpaz, M., Mavligit, G., Keating, M., Walters, R.S. & Gutterman, J.U. (1983) Human leukocyte interferon to control thrombocytosis in chronic myeloid leukaemia. Annals of Internal Medicine, 99, 789-792.
34. Turri, D., Mitra, M.E., Di Trapani, R., Lipani, M.G., Perricone, R. & Cajozzo, A. (1991) Interferon in polycythemia vera and essential thrombocythemia. Haematologica, 76, 75-77.
35. Wasserman, L.R. (1976) The treatment of polycythemia vera. Seminars in Haematology, 13, 57-78.
36. Weinfeld, A., Swolin, B. & Westin, J. (1994) Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: prospective study of efficacy and leukaemogenicity with therapeutic implications. European Journal of Haematology, 52, 134-139.